Biden administration proposes expanding Medicare and Medicaid coverage for weight-loss drugs, aiding millions.

The Biden administration proposes to expand Medicare and Medicaid coverage for weight-loss drugs like Wegovy and Zepbound, making them accessible to 3.4 million Medicare and 4 million Medicaid enrollees. The proposal, which could cost taxpayers $35 billion over a decade, faces potential opposition from Robert F. Kennedy Jr., who opposes the drugs. The rule, if implemented, could reduce out-of-pocket costs by up to 95% and aims to prevent chronic conditions related to obesity.

November 26, 2024
442 Articles